Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 966.20 | 1445 / 1445 | 100% | 66.34 | 183 / 183 |
uterus | 100% | 660.47 | 170 / 170 | 100% | 75.20 | 458 / 459 |
ovary | 100% | 645.76 | 180 / 180 | 100% | 79.43 | 429 / 430 |
intestine | 100% | 795.29 | 965 / 966 | 97% | 50.66 | 512 / 527 |
skin | 99% | 1463.55 | 1782 / 1809 | 99% | 54.28 | 465 / 472 |
bladder | 100% | 756.05 | 21 / 21 | 97% | 58.98 | 488 / 504 |
stomach | 97% | 632.34 | 350 / 359 | 98% | 54.51 | 280 / 286 |
adrenal gland | 100% | 760.72 | 258 / 258 | 93% | 34.15 | 213 / 230 |
brain | 100% | 1291.46 | 2638 / 2642 | 88% | 33.74 | 620 / 705 |
breast | 99% | 525.52 | 456 / 459 | 88% | 29.44 | 979 / 1118 |
lung | 99% | 731.15 | 572 / 578 | 86% | 42.38 | 999 / 1155 |
prostate | 100% | 744.73 | 244 / 245 | 86% | 16.94 | 431 / 502 |
thymus | 98% | 515.81 | 642 / 653 | 39% | 14.47 | 233 / 605 |
pancreas | 43% | 110.72 | 142 / 328 | 88% | 23.69 | 157 / 178 |
liver | 65% | 256.52 | 146 / 226 | 61% | 15.20 | 249 / 406 |
kidney | 99% | 585.73 | 88 / 89 | 22% | 4.12 | 196 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 99.46 | 29 / 29 |
spleen | 100% | 1123.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.30 | 1 / 1 |
blood vessel | 99% | 684.89 | 1323 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 589.67 | 1191 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1831.29 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 710.83 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 17.60 | 73 / 80 |
muscle | 82% | 373.20 | 659 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051301 | Biological process | cell division |
GO_0010994 | Biological process | free ubiquitin chain polymerization |
GO_1904668 | Biological process | positive regulation of ubiquitin protein ligase activity |
GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
GO_0044314 | Biological process | protein K27-linked ubiquitination |
GO_0010458 | Biological process | exit from mitosis |
GO_0036211 | Biological process | protein modification process |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0035519 | Biological process | protein K29-linked ubiquitination |
GO_0085020 | Biological process | protein K6-linked ubiquitination |
GO_0005680 | Cellular component | anaphase-promoting complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005524 | Molecular function | ATP binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0010997 | Molecular function | anaphase-promoting complex binding |
Gene name | UBE2S |
Protein name | Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S) E2 ubiquitin-conjugating enzyme (EC 2.3.2.23) Ubiquitin conjugating enzyme E2 S |
Synonyms | OK/SW-cl.73 E2EPF |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins . Catalyzes 'Lys-11'-linked polyubiquitination. Acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. Acts by specifically elongating 'Lys-11'-linked polyubiquitin chains initiated by the E2 enzyme UBE2C/UBCH10 on APC/C substrates, enhancing the degradation of APC/C substrates by the proteasome and promoting mitotic exit . Also acts by elongating ubiquitin chains initiated by the E2 enzyme UBE2D1/UBCH5 in vitro; it is however unclear whether UBE2D1/UBCH5 acts as an E2 enzyme for the APC/C in vivo. Also involved in ubiquitination and subsequent degradation of VHL, resulting in an accumulation of HIF1A . In vitro able to promote polyubiquitination using all 7 ubiquitin Lys residues, except 'Lys-48'-linked polyubiquitination . . |
Accessions | ENST00000587845.5 Q6NXQ4 ENST00000264552.14 ENST00000589978.1 K7EPJ1 K7EM75 Q16763 |